Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
8.11
-0.41 (-4.81%)
At close: Mar 11, 2026, 4:00 PM EDT
8.10
-0.01 (-0.12%)
After-hours: Mar 11, 2026, 5:03 PM EDT
Revenue by Segment
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | Jun '18 Jun 30, 2018 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 |
|---|
Pharmaceutical Research and Development Business | 1.83M | 2.48M | 1,000.00 | 10.00K | 15.18M | | | | | |
Pharmaceutical Research and Development Business Growth | -26.28% | 248000.00% | -90.00% | -99.93% | 1436.54% | | | | | |
| 1.83M | 2.48M | 1,000.00 | 10.00K | 15.18M | | | | | |
| -26.28% | 248000.00% | -90.00% | -99.93% | 1436.54% | | | | | |
Revenue by Geography
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | Jun '18 Jun 30, 2018 | Jun '17 Jun 30, 2017 | Jun '16 Jun 30, 2016 |
|---|
| - | 2.31M | - | - | - | | | | | |
| 42.00K | - | - | - | - | | | | | |
| - | - | - | - | 10.01M | | | | | |
| - | - | - | - | 5.18M | | | | | |
| 42.00K | 2.31M | - | - | 15.18M | | | | | |
| -98.18% | - | - | - | - | | | | | |
Source: S&P Global Market Intelligence.
